LMMYExousia Bio, Inc.
The schedule
- Thu15Oct
Capital Structure Update and Dilution Risk
- Fri15Jan
Exchange Compliance Status Update
- Fri12Mar
Q3 2026 Earnings Release
- Fri11Jun
Q4 2026 Earnings Release
- Fri10Sep
Q1 2027 Earnings Release
Past
- Fri11Sep
Q2 2026 Earnings Release
- Thu13Aug
Actual outcome: Bear · $0.02 at outcome
LMMY reported earnings below expectations and cut guidance, triggering a sharp sell-off. The company warned of weaker-than-anticipated demand and operational challenges, leading to a significant price drop within the ultra-short time frame. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: -59.6% from 2026-08-13 to 2026-08-17 (~3.7σ vs typical 1d vol). Target evaluation date 2026-08-18 (not yet reached as of 2026-08-17). Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-18: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-08-18 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-10 observed.
LMMY reported earnings below expectations and cut guidance, triggering a sharp sell-off. The company warned of weaker-than-anticipated demand and operational challenges, leading to a significant price drop within the ultra-short time frame. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: -59.6% from 2026-08-13 to 2026-08-17 (~3.7σ vs typical 1d vol). Target evaluation date 2026-08-18 (not yet reached as of 2026-08-17). Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-18: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-08-18 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: -59.6% from 2026-08-13 (~3.7σ). Target date 2026-08-18 reached; move through 2026-09-10 observed.